Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 7, 2013, Pages 1706-1713

  Robciuc, Marius R ^a,b   Maranghi, Marianna ^e   Lahikainen, Anna ^a   Rader, Daniel ^c   Bensadoun, Andre ^d   Oorni, Katariina ^b   Metso, Jari ^a   Minicocci, Ilenia ^e   Ciociola, Ester ^a   Ceci, Fabrizio ^e   Montali, Anna ^e   Arca, Marcello ^e   Ehnholm, Christian ^e   Jauhiainen, Matti ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b WIHURI RESEARCH INSTITUTE   (Finland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Department of Obstetrics Gynecology   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

ANGPTL3 protein; ANGPTL4 protein; Endothelial lipase; Familial combined hypolipidemia; Fatty acids; Hepatic lipase; Human; Lipoprotein lipase; Nonesterified

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 3; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; GEL FILTRATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPOLIPEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID COMPOSITION; LIPOLYSIS; LOSS OF FUNCTION MUTATION; MALE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANGPTL3 PROTEIN, HUMAN; ANGPTL4 PROTEIN, HUMAN; ENDOTHELIAL LIPASE, HUMAN; FAMILIAL COMBINED HYPOLIPIDEMIA; FATTY ACIDS, NONESTERIFIED; HEPATIC LIPASE, HUMAN; LIPOPROTEIN LIPASE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOPOIETINS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; FATTY ACIDS, NONESTERIFIED; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPOBETALIPOPROTEINEMIAS; INSULIN; INSULIN RESISTANCE; ITALY; LINEAR MODELS; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MUTATION; TRIGLYCERIDES; UP-REGULATION;

EID: 84879123717     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301397     Document Type: Article

References (33)

1. Musunuru K, Pirruccello JP, Do R, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med. 2010;363:2220-2227.
2. Pulai JI, Neuman RJ, Groenewegen AW, Wu J, Schonfeld G. Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families. Am J Med. Genet. 1998;76:79-86.
3. Minicocci I, Montali A, Robciuc MR, et al. Mutations in the ANGPTL3 gene and familial combined hypolipidemia: A clinical and biochemical characterization. J Clin Endocrinol Metab. 2012;97:1266.
4. Martín-Campos JM, Roig R, Mayoral C, Martinez S, Martí G, Arroyo JA, Julve J, Blanco-Vaca F. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation. Clin Chim Acta. 2012;413:552-555.
5. Pisciotta L, Favari E, Magnolo L, et al. Characterization of three kindred with familial combined hypolipidemia due to loss of function mutations of ANGPTL3. Circulation. 2011;5:42-50.
6. Noto D, Cefalù AB, Valenti V, et al. Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia. Arterioscler Thromb Vasc Biol. 2012;32:805-809.
7. Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, Horikoshi H, Furukawa H. Angptl3 regulates lipid metabolism in mice. Nat Genet. 2002;30:151-157.
8. Kersten S. Angiopoietin-like proteins and lipid metabolism. In:Ehnholm C, ed. Cellular Lipid Metabolism. Heidelberg, Germany: Springer Verlag Berlin-Heidelberg; 2009:237-249.
9. Shimizugawa T, Ono M, Shimamura M, et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem. 2002;277:33742-33748.
10. Koster A, Chao YB, Mosior M, et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: Regulation of triglyceride metabolism. Endocrinology. 2005;146:4943-4950.
11. Liu JJ. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases. J Biol Chem. 2010;285:27561-27570.
12. Shimamura M, Matsuda M, Yasumo H, et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol. 2007;27:366-372.
13. Jin WW. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab. 2007;6:129-136.
14. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713.
15. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161-169.
16. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40:189-197.
17. Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, Cohen JC. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest. 2009;119:70-79.
18. Shimamura M, Matsuda M, Kobayashi S, Ando Y, Ono M, Koishi R, Furukawa H, Makishima M, Shimomura I. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun. 2003;301:604-609.
19. Nakajima K, Kobayashi J, Mabuchi H, Nakano T, Tokita Y, Nagamine T, Imamura S, Ai M, Otokozawa S, Schaefer EF. Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma. Ann Clin Biochem. 2010;47:423-431.
20. Shan L, Yu XC, Liu Z, Hu Y, Sturgis LT, Miranda ML, Liu Q. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem. 2009;284:1419-1424.
21. Christensen P, Christoffersen C, Lindholm M, Nielsen L. Genetic inhibition of apoB secretion is parallelled by reduced secretion of apoA-I from liver cells. Abstract, European Lipoprotein Club Meeting, September 2012, Tutzing, Germany. 2012.
22. Robciuc MR, Tahvanainen E, Jauhiainen M, Ehnholm C. Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J Lipid Res. 2010;51:824-831.
23. Zhang YL, Hernandez-Ono A, Ko C, Yasunaga K, Huang LS, Ginsberg HN. Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. J Biol Chem. 2004;279:19362-19374.
24. Elias N, Patterson BW, Schonfeld G. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene. Arterioscler Thromb Vasc Biol. 2000;20:1309-1315.
25. Kovacs P, Stumvoll M. Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab. 2005;19:625-635.
26. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18:139-143.
27. Gray NE, Lam LN, Yang K, Zhou AY, Koliwad S, Wang JC. Angiopoietinlike 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes. J Biol Chem. 2012;287:8444-8456.
28. Robciuc MR, Naukkarinen J, Ortega-Alonso A, Tyynismaa H, Raivio T, Rissanen A, Kaprio J, Ehnholm C, Jauhiainen M, Pietiläinen KH. Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins. J Lipid Res. 2011;52:1575-1582.
29. Staiger H, Haas C, Machann J, Werner R, Weisser M, Schick F, Machicao F. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes. 2009;58:579-585.
30. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Müller M, Kersten S. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem. 2006;281:934-944.
31. Robciuc MR, Skrobuk P, Anisimov A, Olkkonen VM, Alitalo K, Eckel RH, Koistinen HA, Jauhiainen M, Ehnholm C. Angiopoietinlike 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes. PLoS ONE. 2012;10:1-13.
32. Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks HF, Hesselink MK, Schrauwen P, Müller M. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol. 2009;29:969-974.
33. Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E, Valenzuela DM, Murphy AJ, Cohen JC, Hobbs HH. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A. 2012;109:19751-19756.